Fennec Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patient…

Biotechnology
US, Research Triangle Park [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Fennec Pharmaceuticals Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Fennec Pharmaceuticals Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Fennec Pharmaceuticals Inc..

End of FENC's Analysis
CIK: 1211583 CUSIP: 31447P100 ISIN: CA31447P1009 LEI: - UEI: -
Secondary Listings
FENC has no secondary listings inside our databases.